---
layout: page
title: health endpoint
description: with SOLAR-CHS-CCHC, PCa patients from UA Cancer Center
img: assets/img/6.jpg
importance: 2
category: work
giscus_comments: false
related_publications: true
---

Application of omics techniques on various health endpoints, including prostate cancer, bone health, and liver disease are listed below:

<div class="row justify-content-sm-center">
    <div class="col-sm-8 mt-3 mt-md-0">
        {% include figure.liquid path="assets/img/6.jpg" title="example image" class="img-fluid rounded z-depth-1" %}
    </div>
    <div class="col-sm-4 mt-3 mt-md-0">
        {% include figure.liquid path="assets/img/10.jpg" title="example image" class="img-fluid rounded z-depth-1" %}
    </div>
</div>
<div class="caption">
    Random images.
</div>

- **Prostates cancer**, **Metabolomics**: Evaluating Differential Metabolic Profile by Prostate Cancer Grade among Prostate Cancer Patients
  - Conducted metabolomics analysis on 22 urine samples from prostate cancer patients who were disgnozed with prostate cancer
  - Developed and validated statistical models to compare metabolic profiles across high vs. low PCa risk group
  - Lead author for a manuscript (submitted to Metabolites) {% cite Liu_2025_7 %}

- **Bone Health**, **Metabolomics**: TBD
  - Multi-cohort spanning from childhood, adolescence, to young adulthood
  - Analyzed 304 plasma samples for BMD-related metabolic signals 
  - Integrated metabolomics datasets for comparative analysis
  - Lead author for a manuscript (under development) 

- **Liver Disease**, **Exposomics**: TBD
  - TBD